Hawksbill Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 75.00 K
- Company Age 4 Year, 16 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.30 M
- Revenue Growth -48.96%
- Profit Growth -49.11%
- Ebitda 1326.06%
- Net Worth 15.19%
- Total Assets 21.44%
About Hawksbill Pharmaceuticals
Hawksbill Pharmaceuticals Private Limited (HPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 05 February 2021 (Four years 16 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 75.00 K .
The company currently has active open charges totaling ₹2.30 M.
Bishwas Sinha, Astha Sinha, and Aahna Sinha serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230GJ2021PTC120020
- Company No.
120020
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Feb 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Hawksbill Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bishwas Sinha  | Director | 05-Feb-2021 | Current |
| Astha Sinha | Director | 21-Aug-2023 | Current |
| Aahna Sinha | Director | 21-Aug-2023 | Current |
Financial Performance of Hawksbill Pharmaceuticals.
Hawksbill Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 48.96% decrease. The company also saw a substantial fall in profitability, with a 49.11% decrease in profit. The company's net worth Soared by an impressive increase of 15.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hawksbill Pharmaceuticals?
Unlock access to Hawksbill Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹2.30 M
₹0
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 0.23 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Sep 2023 | Indian Overseas Bank | ₹1.50 M | Open |
| 31 Mar 2022 | Indian Overseas Bank | ₹0.80 M | Open |
How Many Employees Work at Hawksbill Pharmaceuticals?
Hawksbill Pharmaceuticals has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hawksbill Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hawksbill Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
